Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mengcui Gui"'
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: Refractory generalized myasthenia gravis (GMG) remains a substantial therapeutic challenge. Telitacicept, a recombinant human B-lymphocyte stimulator receptor-antibody fusion protein, holds promise for interrupting the immunopathology of
Externí odkaz:
https://doaj.org/article/3d05c082715f4b438e498585f9645ef9
Autor:
Zhuajin Bi, Jiayang Zhan, Qing Zhang, Huajie Gao, Mengge Yang, Huizhen Ge, Mengcui Gui, Jing Lin, Bitao Bu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectivesTo describe the clinical predictors and immune-related factors for exacerbation in adults with well-controlled generalized myasthenia gravis (GMG).MethodsWe conducted a retrospective analysis of 585 adults with well-controlled GMG from our
Externí odkaz:
https://doaj.org/article/e17bc46453c343c99d3e31b88d7be3f9
Autor:
Zhuajin Bi, Yayun Cao, Chenchen Liu, Mengcui Gui, Jing Lin, Qing Zhang, Yue Li, Suqiong Ji, Bitao Bu
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Objective: To identify the factors that predict the remission and relapses in myasthenia gravis (MG) patients improved by prednisone and tacrolimus treatment. Methods: A retrospective, observational cohort analysis of MG patients who achieved remissi
Externí odkaz:
https://doaj.org/article/9772b67190fd4c788799703e87887ea4
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
ObjectivesTo evaluate the long-term outcome of tacrolimus for childhood-onset myasthenia gravis (CMG) with an inadequate response to glucocorticoids, and investigate factors associated with favorable outcomes following tacrolimus treatment.MethodsA r
Externí odkaz:
https://doaj.org/article/5dc771cc18804b6eb4a5c0bedecb2b8d
Publikováno v:
European Journal of Pediatric Surgery. 32:543-549
Introduction The effect of thymectomy on the treatment of childhood-onset myasthenia gravis (CMG) remains debatable. The objective of this study was to evaluate the clinical outcome and relevant prognostic factors of thymectomy for CMG patients. Mate
Publikováno v:
Muscle & Nerve. 65:553-559
Immunophenotypes are related to the therapeutic efficacy of specific immunomodulating agents in patients with myasthenia gravis (MG), but the relationship of immunophenotype to the presence or absence of thyroid antibodies is unknown. This study aims
Distinct Immunological Features of Inflammatory Demyelinating Diseases of the Central Nervous System
Publikováno v:
Neuroimmunomodulation. 29:220-230
Objective: The immunological features between neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), lacked systemic comparisons. Accordingly, we aimed to
Autor:
Zhuajin Bi, Jiayang Zhan, Qing Zhang, Huajie Gao, Mengge Yang, Huizhen Ge, Mengcui Gui, Jing Lin, Bitao Bu
Publikováno v:
Frontiers in Immunology; 2023, p1-10, 10p
Autor:
Qing, Zhang, Huizhen, Ge, Mengcui, Gui, Mengge, Yang, Zhuajin, Bi, Xue, Ma, Zhongya, Gu, Shu, Peng, Tao, Chen, Bitao, Bu
Publikováno v:
Annals of Translational Medicine. 10:1155-1155
Nearly 10% to 20% of myasthenia gravis (MG) patients are refractory to conventional treatment for unclear reasons. The study aimed to explore the relationship between drug metabolism gene polymorphisms and refractory MG.One hundred and thirty-one MG
Publikováno v:
Medicine. 98:e18104
Rationale Myasthenia gravis (MG) and Guillain-Barre syndrome (GBS) are 2 common neurologic autoimmune diseases. Although both the diseases can present with acute or subacute onset of muscular weakness involving the limbs and bulb, the coexistence in